The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tze, L. E.
Right arrow Articles by Behrens, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tze, L. E.
Right arrow Articles by Behrens, T. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2000, 165: 6796-6802.
Copyright © 2000 by The American Association of Immunologists

Ig Light Chain Receptor Editing in Anergic B Cells1

Lina E. Tze, Elizabeth A. Baness, Keli L. Hippen and Timothy W. Behrens2

Department of Medicine, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455

Receptor editing in the bone marrow (BM) serves to modify the Ag receptor specificity of immature self-reactive B cells, while anergy functionally silences self-reactive clones. Here, we demonstrate that anergic B cells in hen egg lysozyme Ig (HEL-Ig)/soluble HEL double transgenic mice show evidence of having undergone receptor editing in vivo, as demonstrated by the presence of elevated levels of endogenous {kappa} light chain rearrangements in the BM and spleen. In an in vitro IL-7-driven BM culture system, HEL-Ig BM B cells grown in the presence of soluble HEL down-regulated surface IgM expression and also showed induction of new endogenous {kappa} light chain rearrangements. Using a panel of soluble protein ligands with reduced affinity for the HEL-Ig receptor, the editing response was shown to correlate in a dose-dependent fashion with the strength of signaling through the B cell receptor. The finding that the level of B cell receptor cross-linking sufficient to induce anergy in B cells is also capable of engaging the machinery required for receptor editing suggests an intimate relationship between these two mechanisms in maintaining B cell tolerance.




This article has been cited by other articles:


Home page
JEMHome page
E. J. Cadera, F. Wan, R. H. Amin, H. Nolla, M. J. Lenardo, and M. S. Schlissel
NF-{kappa}B activity marks cells engaged in receptor editing
J. Exp. Med., August 3, 2009; 206(8): 1803 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Taylor, B. S. Cobb, L. Bruno, Z. Webster, A. G. Fisher, and M. Merkenschlager
A reappraisal of evidence for probabilistic models of allelic exclusion
PNAS, January 13, 2009; 106(2): 516 - 521.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Diz, S. K. McCray, and S. H. Clarke
B Cell Receptor Affinity and B Cell Subset Identity Integrate to Define the Effectiveness, Affinity Threshold, and Mechanism of Anergy
J. Immunol., September 15, 2008; 181(6): 3834 - 3840.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kiefer, P. B. Nakajima, J. Oshinsky, S. H. Seeholzer, M. Radic, G. C. Bosma, and M. J. Bosma
Antigen Receptor Editing in Anti-DNA Transitional B Cells Deficient for Surface IgM
J. Immunol., May 1, 2008; 180(9): 6094 - 6106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Schram, L. E. Tze, L. B. Ramsey, J. Liu, L. Najera, A. L. Vegoe, R. R. Hardy, K. L. Hippen, M. A. Farrar, and T. W. Behrens
B Cell Receptor Basal Signaling Regulates Antigen-Induced Ig Light Chain Rearrangements
J. Immunol., April 1, 2008; 180(7): 4728 - 4741.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. M. Caucheteux, C. Vernochet, J. Wantyghem, M.-C. Gendron, and C. Kanellopoulos-Langevin
Tolerance induction to self-MHC antigens in fetal and neonatal mouse B cells
Int. Immunol., January 1, 2008; 20(1): 11 - 20.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Bai, Y. Chen, Y. He, X. Dai, X. Lin, R. Wen, and D. Wang
Phospholipase C{gamma}2 Contributes to Light-Chain Gene Activation and Receptor Editing
Mol. Cell. Biol., September 1, 2007; 27(17): 5957 - 5967.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Roy, N.-H. Chang, Y. Cai, G. Bonventi, and J. Wither
Aberrant IgM Signaling Promotes Survival of Transitional T1 B Cells and Prevents Tolerance Induction in Lupus-Prone New Zealand Black Mice
J. Immunol., December 1, 2005; 175(11): 7363 - 7371.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H.-Y. Ryu, J. K. Emberley, J. J. Schlezinger, L. L. Allan, S. Na, and D. H. Sherr
Environmental Chemical-Induced Bone Marrow B Cell Apoptosis: Death Receptor-Independent Activation of a Caspase-3 to Caspase-8 Pathway
Mol. Pharmacol., October 1, 2005; 68(4): 1087 - 1096.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Hippen, B. R. Schram, L. E. Tze, K. A. Pape, M. K. Jenkins, and T. W. Behrens
In Vivo Assessment of the Relative Contributions of Deletion, Anergy, and Editing to B Cell Self-Tolerance
J. Immunol., July 15, 2005; 175(2): 909 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. Swanson-Mungerson, R. G. Caldwell, R. Bultema, and R. Longnecker
Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to Autoantigen
J. Virol., June 15, 2005; 79(12): 7355 - 7362.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Hillion, A. Saraux, P. Youinou, and C. Jamin
Expression of RAGs in Peripheral B Cells outside Germinal Centers Is Associated with the Expression of CD5
J. Immunol., May 1, 2005; 174(9): 5553 - 5561.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Schlezinger, G. J. Howard, C. H. Hurst, J. K. Emberley, D. J. Waxman, T. Webster, and D. H. Sherr
Environmental and Endogenous Peroxisome Proliferator-Activated Receptor {gamma} Agonists Induce Bone Marrow B Cell Growth Arrest and Apoptosis: Interactions between Mono(2-ethylhexyl)phthalate, 9-cis-Retinoic Acid, and 15-Deoxy-{Delta}12,14-prostaglandin J2
J. Immunol., September 1, 2004; 173(5): 3165 - 3177.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Swanson, S. L. Kuslak, W. Fang, L. Tze, P. Gaffney, S. Selby, K. L. Hippen, G. Nunez, C. L. Sidman, and T. W. Behrens
Fatal Acute Lymphoblastic Leukemia in Mice Transgenic for B Cell-Restricted bcl-xL and c-myc
J. Immunol., June 1, 2004; 172(11): 6684 - 6691.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Feuerstein, D. Shivers, F. Chen, R. A. Eisenberg, and T. H. Finkel
Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors
Int. Immunol., August 1, 2003; 15(8): 975 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. E. Tze, K. L. Hippen, and T. W. Behrens
Late Immature B Cells (IgMhighIgDneg) Undergo a Light Chain Receptor Editing Response to Soluble Self-Antigen
J. Immunol., July 15, 2003; 171(2): 678 - 682.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Mehr, G. Shahaf, A. Sah, and M. Cancro
Asynchronous differentiation models explain bone marrow labeling kinetics and predict reflux between the pre- and immature B cell pools
Int. Immunol., March 1, 2003; 15(3): 301 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Schlezinger, B. A. Jensen, K. K. Mann, H.-Y. Ryu, and D. H. Sherr
Peroxisome Proliferator-Activated Receptor {gamma}-Mediated NF-{kappa}B Activation and Apoptosis in Pre-B Cells
J. Immunol., December 15, 2002; 169(12): 6831 - 6841.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.